NEW YORK, Oct. 29 (GenomeWeb News) - STMicroelectronics and MobiDiag announced today an agreement to jointly develop a MEMS biochip for genomic-based infectious disease detection.
The companies did not disclose the financial terms of the agreement.
"The ST/MobiDiag solution will reduce the cost and complexity of the diagnosis by producing consumables that will be very competitive and offer superior performance compared to existing solutions," the companies said in a statement.
STMicroelectronics, a Geneva-based, publicly traded semiconductor company, has developed a disposable silicon MEMS chip that uses PCR to perform DNA amplification and detection of DNA sequence. The channels in the silicon act microfluidically to carry the sample and reagents and resistive heating elements control temperature, according to the company.
MobiDiag, of Helsinki, Finland, specializes in biochip-based molecular diagnostics of infectious diseases. The company has developed the ability to analyze and manage microbial genomic data to design panels for clinical diagnosis of microbial pathogens, according to its website.